Morgan Stanley Maintains Overweight on Endava, Lowers Price Target to $70
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst James Faucette maintains an Overweight rating on Endava (NYSE:DAVA) but lowers the price target from $95 to $70.
May 24, 2023 | 12:09 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Morgan Stanley maintains an Overweight rating on Endava (NYSE:DAVA) and lowers the price target from $95 to $70.
Morgan Stanley's lowered price target on Endava may cause short-term uncertainty among investors, but the Overweight rating indicates a positive outlook for the stock. The impact on the stock price is expected to be neutral in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100